We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNP icon
526
CenterPoint Energy
CNP
$26.8B
$2.36M 0.01%
82,561
+56,829
+221% +$1.69M
AGS
527
DELISTED
PlayAGS
AGS
$2.36M 0.01%
121,462
+47,732
+65% +$1.03M
CHUY
528
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$2.36M 0.01%
103,022
+19,596
+23% +$422K
FNV icon
529
Franco-Nevada
FNV
$46B
$2.33M 0.01%
+27,400
New +$2.07M
HHR
530
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$2.33M 0.01%
+143,414
New +$2.35M
GTES icon
531
Gates Industrial Corporation Ltd.
GTES
$7.15B
$2.32M 0.01%
203,606
+166,666
+451% +$2.24M
STNG icon
532
Scorpio Tankers
STNG
$3.81B
$2.32M 0.01%
78,553
-71,024
-47% -$1.8M
TDOC icon
533
Teladoc Health
TDOC
$1.3B
$2.32M 0.01%
34,926
+34,296
+5,444% +$2M
EBS icon
534
Emergent Biosolutions
EBS
$248M
$2.29M 0.01%
47,415
+42,715
+909% +$2.05M
SAH icon
535
Sonic Automotive
SAH
$2.61B
$2.28M 0.01%
+97,833
New +$1.88M
MTB icon
536
M&T Bank
MTB
$36.2B
$2.26M 0.01%
13,276
-7,410
-36% -$1.23M
SEIC icon
537
SEI Investments
SEIC
$12.6B
$2.26M 0.01%
+40,254
New +$2.17M
CIT
538
DELISTED
CIT Group Inc.
CIT
$2.23M 0.01%
42,359
+40,659
+2,392% +$2.06M
CONN
539
DELISTED
Conn's Inc.
CONN
$2.22M 0.01%
124,778
-61,272
-33% -$1.35M
RDS.B
540
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$2.22M 0.01%
33,838
-173,881
-84% -$11.3M
SHEN icon
541
Shenandoah Telecom
SHEN
$746M
$2.2M 0.01%
+57,132
New +$2.37M
QTS
542
DELISTED
QTS REALTY TRUST, INC.
QTS
$2.2M 0.01%
+47,580
New +$2.17M
CVE icon
543
Cenovus Energy
CVE
$52.1B
$2.19M 0.01%
248,200
+149,400
+151% +$1.35M
CAE icon
544
CAE Inc. Common Shares
CAE
$8.74B
$2.19M 0.01%
81,337
-71,737
-47% -$1.75M
ALSN icon
545
Allison Transmission
ALSN
$9.82B
$2.17M 0.01%
46,916
+44,916
+2,246% +$2.04M
FCX icon
546
Freeport-McMoran
FCX
$97.5B
$2.17M 0.01%
+186,746
New +$2.17M
CRTO icon
547
Criteo S.A. Ordinary Shares
CRTO
$923M
$2.16M 0.01%
125,509
+88,916
+243% +$1.75M
MORF
548
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2.14M 0.01%
+107,774
New +$2.04M
C icon
549
Citigroup
C
$226B
$2.13M 0.01%
30,404
-66,052
-68% -$4.42M
LPLA icon
550
LPL Financial
LPLA
$28.6B
$2.13M 0.01%
+26,092
New +$2.06M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.